Applied Radiology
LOGIN TO YOUR MYAR CE ACCOUNT
Forgot Your Password? Register Submit

Recent Advances in Contrast-Enhanced Cardiac MRI

Recent Advances in Contrast-Enhanced Cardiac MRI
Original Program Date: August 8, 2017     Credits: 1     Format: Audio Visual     Run Time: 60 Minutes     Fee: No Charge
Uncertainty still exists regarding the appropriate and effective routine assessment of myocardial disease with contrast-enhanced MRI. Today more recent and novel MRI myocardial characterization techniques exist, such as T1 and T2 mapping. However, insufficient awareness of the pitfalls in cardiac MRI diagnosis frequently contribute to missed diagnosis in the workup of patients with myocardial infarction and other diseases of the heart muscle.
This Expert Forum featuring Dr. Joseph Schoepf will address these issues and provide a review of the basic principles and recent advances in contrast-enhanced Cardiac MR imaging. Particular emphasis will be placed on the MR assessment of diseases of the myocardium and novel methods for their granular characterization.
Following Dr. Schoepf's presentation, questions from the audience were addressed.
To View The On-Demand Program and Claim Credit Select Profession

Contrast Enhanced MRI 2017 Update: New Issues | New Indications

Original Program Date: January 19, 2017     Credits: 1     Format: Audio Visual     Run Time: 60 Minutes     Fee: No Charge
With a wide selection of gadolinium-based contrast agents now available in the US Market; MR imaging professionals must understand the chemical structure, differences in stability and relaxivity and safety profiles of each of these FDA approved MR agents.
Following Dr. Tanenbaum's presentation, questions from the audience were addressed.
To View The On-Demand Program and Claim Credit Select Profession
Safety of Gadolinium-Based Contrast Agents in Adult & Pediatric Patients
A 4-Part Educational Webcast Series

A review of the literature indicates an increased incidence of gadolinium deposition in the brain as a result of repeated contrast-enhanced MR imaging procedures. With a wide selection of gadolinium-based contrast agents available; imaging professionals must be aware of their chemical make-up when selecting the best agent for a particular study.

In this updated 4-Part webcast series, chaired by Lawrence N. Tanenbaum, MD FACR and featuring an esteemed faculty, which includes Dr. Kenneth Maravilla, Dr. Donna Roberts, Dr. Richard Semelka and Dr. Lawrence Tanenbaum; we review the current role of gadolinium-based contrast media in adult and pediatric patients through didactic presentation and roundtable discussion. In light of recent discoveries, faculty will review the characteristics of a gadolinium-based agent when making choices in patients with both normal and abnormal renal function.

These activities have been supported through an unrestricted educational grant from Guerbet, LLC.

Part 1: Safety of Gadolinium-Based Contrast Agents: Structure, Stability, NSF & Tissue Deposition
Original Program Date: May 17, 2016     Credits: 1     Format: Audio Visual     Run Time: 60 Minutes     Fee: No Charge
In this first (1) of a four-part (4) CME/CE Accredited Expert Forum Webcast Series, Dr. Kenneth Maravilla reviews the safety profiles of the currently available agents, identifies the risk factors for NSF and discusses the current understanding and outstanding issues related to Gadolinium deposition in the brain and other tissues in patients with normal renal function.
Following Dr. Maravilla's presentation, a panel discussion was moderated by Dr. Lawrence Tanenbaum; where questions from the audience were addressed.
Viewing Only, Credits No Longer Available.
Part 2: Gadolinium Based Contrast Agents and Pediatric Long Term Safety
Original Program Date: June 14, 2016     Credits: 1     Format: Audio Visual     Run Time: 60 Minutes     Fee: No Charge
In this second (2) of a four-part (4) CME/CE Accredited Expert Forum Webcast Series, Dr. Donna Roberts will discuss clinical indications for post contrast MR imaging, review the current literature as it relates to gadolinium retention and discuss considerations for selecting a GBCA when imaging pediatric patients.
Following Dr. Roberts presentation, a panel discussion was moderated by Dr. Lawrence Tanenbaum; where questions from the audience were addressed.
Viewing Only, Credits No Longer Available.
Part 3: Contrast Enhanced Body MR Imaging: Making Diagnoses While Managing Risks
Original Program Date: July 12, 2016     Credits: 1     Format: Audio Visual     Run Time: 60 Minutes     Fee: No Charge
In this third (3) of a four-part (4) CME/CE Accredited Expert Forum Webcast Series, Dr. Richard Semelka shares his clinical experiences and best practices as it relates to the use of Gadolinium Based Contrast Agents (GBCAs) in body MR imaging.
Following Dr. Semelka's presentation, a panel discussion was moderated by Dr. Lawrence Tanenbaum; where questions from the audience were addressed.
Viewing Only, Credits No Longer Available.
Part 4: Contrast Enhanced Neuro MRI: New Issues, New Indications
Original Program Date: August 18, 2016     Credits: 1     Format: Audio Visual     Run Time: 60 Minutes     Fee: No Charge
In this final CME/CE Accredited Expert Forum Webcast of our four-part series, Dr. Lawrence Tanenbaum reviews contrast-enhanced Neuro MRI with an emphasis on current practices and indications as well as a survey of manifestations of diseases on contrast-enhanced MRI of the brain and spine.
Following Dr. Tanenbaum's presentation, questions from the audience are addressed.
Viewing Only, Credits No Longer Available.